Rani Therapeutics Holdings (RANI) Leases (2022 - 2025)
Rani Therapeutics Holdings (RANI) has 4 years of Leases data on record, last reported at $4.0 million in Q3 2025.
- For Q3 2025, Leases fell 25.98% year-over-year to $4.0 million; the TTM value through Sep 2025 reached $4.0 million, down 25.98%, while the annual FY2024 figure was $5.1 million, 609.75% up from the prior year.
- Leases reached $4.0 million in Q3 2025 per RANI's latest filing, down from $4.4 million in the prior quarter.
- Across five years, Leases topped out at $6.0 million in Q1 2024 and bottomed at $718000.0 in Q4 2023.
- Average Leases over 4 years is $2.9 million, with a median of $1.4 million recorded in 2023.
- Peak YoY movement for Leases: tumbled 32.58% in 2023, then surged 609.75% in 2024.
- A 4-year view of Leases shows it stood at $1.1 million in 2022, then crashed by 32.58% to $718000.0 in 2023, then soared by 609.75% to $5.1 million in 2024, then decreased by 21.17% to $4.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $4.0 million in Q3 2025, $4.4 million in Q2 2025, and $4.7 million in Q1 2025.